Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-26-395893

Director acquired 1,629 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Krebs Andreas · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-09-18 Exercise or conversion : show line 1 in the form +1,629 $35.52 $57,862 21,402 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-18 Exercise or conversion : show line 2 in the form Stock Option (Right to Buy) −1,629 0 D
Loading xslF345X06/ownership.xml…